14.44 USD
+0.2 (+1.4%)
14.49 USD
+0.05 (+0.35%)
We assign a fundamental rating of 7 out of 10 to INMD. INMD was compared to 188 industry peers in the Health Care Equipment & Supplies industry. INMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. A decent growth rate in combination with a cheap valuation! Better keep an eye on INMD. These ratings could make INMD a good candidate for value investing.
1. Profitability
1.1 Basic Checks
In the past year INMD was profitable.
In the past year INMD had a positive cash flow from operations.
In the past 5 years INMD has always been profitable.
In the past 5 years INMD always reported a positive cash flow from operatings.
1.2 Ratios
INMD has a Return On Assets of 20.39%. This is amongst the best in the industry. INMD outperforms 98.94% of its industry peers.
Looking at the Return On Equity, with a value of 22.93%, INMD belongs to the top of the industry, outperforming 95.21% of the companies in the same industry.
INMD has a Return On Invested Capital of 11.95%. This is amongst the best in the industry. INMD outperforms 92.55% of its industry peers.
INMD had an Average Return On Invested Capital over the past 3 years of 22.89%. This is significantly above the industry average of 8.78%.
The 3 year average ROIC (22.89%) for INMD is well above the current ROIC(11.95%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.39% | ||
| ROE | 22.93% | ||
| ROIC | 11.95% |
ROA(3y)23.69%
ROA(5y)26.18%
ROE(3y)26.67%
ROE(5y)29.84%
ROIC(3y)22.89%
ROIC(5y)25.97%
1.3 Margins
INMD's Profit Margin of 41.10% is amongst the best of the industry. INMD outperforms 98.40% of its industry peers.
In the last couple of years the Profit Margin of INMD has grown nicely.
With an excellent Operating Margin value of 23.98%, INMD belongs to the best of the industry, outperforming 94.68% of the companies in the same industry.
INMD's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 78.82%, INMD belongs to the best of the industry, outperforming 91.49% of the companies in the same industry.
INMD's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.98% | ||
| PM (TTM) | 41.1% | ||
| GM | 78.82% |
OM growth 3Y-15.26%
OM growth 5Y-5.64%
PM growth 3Y-0.16%
PM growth 5Y3.28%
GM growth 3Y-1.88%
GM growth 5Y-1.59%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so INMD is creating value.
INMD has less shares outstanding than it did 1 year ago.
INMD has more shares outstanding than it did 5 years ago.
INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
There is no outstanding debt for INMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.39
WACC8.61%
2.3 Liquidity
INMD has a Current Ratio of 9.75. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
INMD has a better Current ratio (9.75) than 92.55% of its industry peers.
INMD has a Quick Ratio of 8.71. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
INMD has a Quick ratio of 8.71. This is amongst the best in the industry. INMD outperforms 91.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.75 | ||
| Quick Ratio | 8.71 |
3. Growth
3.1 Past
The earnings per share for INMD have decreased strongly by -23.67% in the last year.
The Earnings Per Share has been growing by 22.97% on average over the past years. This is a very strong growth
The Revenue for INMD has decreased by -13.98% in the past year. This is quite bad
Measured over the past years, INMD shows a very strong growth in Revenue. The Revenue has been growing by 20.35% on average per year.
EPS 1Y (TTM)-23.67%
EPS 3Y-4.52%
EPS 5Y22.97%
EPS Q2Q%-45.71%
Revenue 1Y (TTM)-13.98%
Revenue growth 3Y3.36%
Revenue growth 5Y20.35%
Sales Q2Q%-28.46%
3.2 Future
INMD is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.66% yearly.
The Revenue is expected to grow by 0.63% on average over the next years.
EPS Next Y-9.5%
EPS Next 2Y-1.61%
EPS Next 3Y1.66%
EPS Next 5YN/A
Revenue Next Year-8.12%
Revenue Next 2Y-1.77%
Revenue Next 3Y0.63%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 9.14, the valuation of INMD can be described as very reasonable.
Based on the Price/Earnings ratio, INMD is valued cheaper than 95.21% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.37, INMD is valued rather cheaply.
With a Price/Forward Earnings ratio of 8.38, the valuation of INMD can be described as very reasonable.
96.28% of the companies in the same industry are more expensive than INMD, based on the Price/Forward Earnings ratio.
INMD is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.20, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.14 | ||
| Fwd PE | 8.38 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INMD is valued cheaply inside the industry as 98.94% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 96.81% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.62 | ||
| EV/EBITDA | 2.79 |
4.3 Compensation for Growth
INMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.4
EPS Next 2Y-1.61%
EPS Next 3Y1.66%
5. Dividend
5.1 Amount
No dividends for INMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
14.44
+0.2 (+1.4%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners58.73%
Inst Owner Change2.1%
Ins Owners10.65%
Ins Owner ChangeN/A
Market Cap912.75M
Revenue(TTM)364.49M
Net Income(TTM)149.81M
Analysts72.31
Price Target17.14 (18.7%)
Short Float %5.51%
Short Ratio4.52
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.86%
Min EPS beat(2)5.11%
Max EPS beat(2)10.61%
EPS beat(4)2
Avg EPS beat(4)-4.56%
Min EPS beat(4)-20.27%
Max EPS beat(4)10.61%
EPS beat(8)4
Avg EPS beat(8)-5.17%
EPS beat(12)7
Avg EPS beat(12)-1.22%
EPS beat(16)11
Avg EPS beat(16)1.65%
Revenue beat(2)1
Avg Revenue beat(2)0.26%
Min Revenue beat(2)-2.87%
Max Revenue beat(2)3.38%
Revenue beat(4)1
Avg Revenue beat(4)-2.96%
Min Revenue beat(4)-9.96%
Max Revenue beat(4)3.38%
Revenue beat(8)2
Avg Revenue beat(8)-5.49%
Revenue beat(12)5
Avg Revenue beat(12)-3.96%
Revenue beat(16)9
Avg Revenue beat(16)-1.5%
PT rev (1m)3.38%
PT rev (3m)3.38%
EPS NQ rev (1m)-8.49%
EPS NQ rev (3m)-8.77%
EPS NY rev (1m)0.32%
EPS NY rev (3m)0.36%
Revenue NQ rev (1m)-1.82%
Revenue NQ rev (3m)-2.14%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)0.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.14 | ||
| Fwd PE | 8.38 | ||
| P/S | 2.5 | ||
| P/FCF | 9.62 | ||
| P/OCF | 9.55 | ||
| P/B | 1.4 | ||
| P/tB | 1.4 | ||
| EV/EBITDA | 2.79 |
EPS(TTM)1.58
EY10.94%
EPS(NY)1.72
Fwd EY11.93%
FCF(TTM)1.5
FCFY10.4%
OCF(TTM)1.51
OCFY10.47%
SpS5.77
BVpS10.34
TBVpS10.34
PEG (NY)N/A
PEG (5Y)0.4
Graham Number19.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.39% | ||
| ROE | 22.93% | ||
| ROCE | 13.12% | ||
| ROIC | 11.95% | ||
| ROICexc | 59.43% | ||
| ROICexgc | 59.43% | ||
| OM | 23.98% | ||
| PM (TTM) | 41.1% | ||
| GM | 78.82% | ||
| FCFM | 26.04% |
ROA(3y)23.69%
ROA(5y)26.18%
ROE(3y)26.67%
ROE(5y)29.84%
ROIC(3y)22.89%
ROIC(5y)25.97%
ROICexc(3y)532.49%
ROICexc(5y)5023.19%
ROICexgc(3y)532.49%
ROICexgc(5y)5023.19%
ROCE(3y)25.13%
ROCE(5y)28.51%
ROICexgc growth 3Y-60.68%
ROICexgc growth 5YN/A
ROICexc growth 3Y-60.68%
ROICexc growth 5YN/A
OM growth 3Y-15.26%
OM growth 5Y-5.64%
PM growth 3Y-0.16%
PM growth 5Y3.28%
GM growth 3Y-1.88%
GM growth 5Y-1.59%
F-Score5
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 86.64% | ||
| Cap/Sales | 0.18% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 108.41% | ||
| Profit Quality | 63.36% | ||
| Current Ratio | 9.75 | ||
| Quick Ratio | 8.71 | ||
| Altman-Z | N/A |
F-Score5
WACC8.61%
ROIC/WACC1.39
Cap/Depr(3y)144.54%
Cap/Depr(5y)147.73%
Cap/Sales(3y)0.22%
Cap/Sales(5y)0.23%
Profit Quality(3y)91.09%
Profit Quality(5y)96.73%
High Growth Momentum
Growth
EPS 1Y (TTM)-23.67%
EPS 3Y-4.52%
EPS 5Y22.97%
EPS Q2Q%-45.71%
EPS Next Y-9.5%
EPS Next 2Y-1.61%
EPS Next 3Y1.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.98%
Revenue growth 3Y3.36%
Revenue growth 5Y20.35%
Sales Q2Q%-28.46%
Revenue Next Year-8.12%
Revenue Next 2Y-1.77%
Revenue Next 3Y0.63%
Revenue Next 5YN/A
EBIT growth 1Y-35.42%
EBIT growth 3Y-12.42%
EBIT growth 5Y13.55%
EBIT Next Year-39.83%
EBIT Next 3Y-11.3%
EBIT Next 5YN/A
FCF growth 1Y-44.72%
FCF growth 3Y-8.8%
FCF growth 5Y16.5%
OCF growth 1Y-44.69%
OCF growth 3Y-8.8%
OCF growth 5Y16.36%
INMODE LTD / INMD FAQ
Can you provide the ChartMill fundamental rating for INMODE LTD?
ChartMill assigns a fundamental rating of 7 / 10 to INMD.
What is the valuation status for INMD stock?
ChartMill assigns a valuation rating of 8 / 10 to INMODE LTD (INMD). This can be considered as Undervalued.
How profitable is INMODE LTD (INMD) stock?
INMODE LTD (INMD) has a profitability rating of 9 / 10.
What are the PE and PB ratios of INMODE LTD (INMD) stock?
The Price/Earnings (PE) ratio for INMODE LTD (INMD) is 9.14 and the Price/Book (PB) ratio is 1.4.
What is the financial health of INMODE LTD (INMD) stock?
The financial health rating of INMODE LTD (INMD) is 8 / 10.